Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01178320 · ClinicalTrials.gov registry record
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 230
- Enrollment target
NCT01178320 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 230 participants.
The verdict
NCT01178320 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 230 participants
- Enrollment target
Study Summary
Heart attacks and strokes caused by the unstable atherosclerotic plaques remain the leading cause of death in the United States. Unstable plaques often have more fat than stable plaques. This study will investigate if a treatment with LDL-lowering plus HDL-raising compared with LDL-lowering alone would more effectively reduce the plaque fat content assessed by magnetic resonance imaging (MRI), therefore, further reducing heart attacks and strokes.
Interventions
- DRUG Simvastatin, simvastatin plus extended-release niacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2008-03 |
| Est. Completion | 2015-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01178320
The ClinicalTrials.gov registry entry for NCT01178320 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Simvastatin, simvastatin plus extended-release niacin is the first listed.
NCT01178320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01178320 about?
NCT01178320 is a clinical study titled "Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)". Heart attacks and strokes caused by the unstable atherosclerotic plaques remain the leading cause of death in the United States. Unstable plaques often have more fat than stable plaques. This study will investigate if a treatment with LDL-lowering plus HDL-raising compared with LDL-lowering alone wo...
What is the current status of trial NCT01178320?
This trial is currently completed. The enrollment target is 230 participants. The study started on 2008-03. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01178320?
The interventions under investigation include: Simvastatin, simvastatin plus extended-release niacin (DRUG).
Who is sponsoring clinical trial NCT01178320?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.